Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20512127 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Omalizumab for Lupus
Conditions: Systemic Lupus Erthematosus;   Sjogren's Syndrome
Intervention: Drug: Omalizumab

Study has passed its completion date and status has not been verified in more than two years.